Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice

Atherosclerosis

Volumn 232, Issue 1, 2014, Pages 40-51

  Hasan, S T ^a   Zingg, J M ^a   Kwan, P ^b   Noble, T ^a   Smith, D ^a   Meydani, M ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Body weight; CD36; Curcumin; FABP 4 aP2; Fatty liver; Ldlr ; Mice

Indexed keywords

ADIPOCYTE PROTEIN 2; CD36 ANTIGEN; CURCUMIN; FAT DROPLET; FATTY ACID BINDING PROTEIN; FECES LIPID; GLUCOSE; GLYCOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; BODY FAT; CONTROLLED STUDY; DESCENDING AORTA; DRUG BLOOD LEVEL; DRUG MEGADOSE; FATTY LIVER; FEMALE; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; MALE; MOUSE; NONHUMAN; OBESITY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WEIGHT GAIN;

ATHEROSCLEROSIS; BODY WEIGHT; CD36; CURCUMIN; FABP-4/AP2; FATTY LIVER; LDLR(-/-); MICE;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD36; ATHEROSCLEROSIS; BODY WEIGHT; CELL LINE; CELLS, CULTURED; CURCUMIN; CYTOKINES; DIET, HIGH-FAT; FATTY ACID-BINDING PROTEINS; FATTY LIVER; FEMALE; HUMANS; INFLAMMATION; LIPID METABOLISM; LIPOPROTEINS, LDL; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXYGEN; RECEPTORS, LDL; TRIGLYCERIDES;

EID: 84891609531     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.10.016     Document Type: Article

References (63)

1. Ross R. Atherosclerosis: an inflammatory disease. NEngl J Med 1999, 340:115-126.
2. Olszanecki R., Jawien J., Gajda M., Mateuszuk L., Gebska A., Korabiowska M., et al. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. JPhysiol Pharmacol 2005, 56:627-635.
3. Poolsup N., Suksomboon N., Setwiwattanakul W. Efficacy of various antidiabetic agents as add-on treatments to metformin in type 2 diabetes mellitus: systematic review and meta-analysis. ISRN Endocrinol 2012, 2012:798146.
4. Ramirez-Tortosa M.C., Mesa M.D., Aguilera M.C., Quiles J.L., Baro L., Ramirez-Tortosa C.L., et al. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 1999, 147:371-378.
5. Quiles J.L., Mesa M.D., Ramirez-Tortosa C.L., Aguilera C.M., Battino M., Gil A., et al. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 2002, 22:1225-1231.
6. Pelton P.D., Zhou L., Demarest K.T., Burris T.P. PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun 1999, 261:456-458.
7. Makowski L., Brittingham K.C., Reynolds J.M., Suttles J., Hotamisligil G.S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. JBiol Chem 2005, 280:12888-12895.
8. Makowski L., Boord J.B., Maeda K., Babaev V.R., Uysal K.T., Morgan M.A., et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001, 7:699-705.
9. Boord J.B., Maeda K., Makowski L., Babaev V.R., Fazio S., Linton M.F., et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 2004, 110:1492-1498.
10. Nicholson A.C., Hajjar D.P., Zhou X., He W., Gotto A.M., Han J. Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression. Br J Pharmacol 2007, 151:807-815.
11. Ejaz A., Wu D., Kwan P., Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. JNutr 2009, 139:919-925.
12. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93:229-240.
13. Greenspan P., Mayer E.P., Fowler S.D. Nile red: a selective fluorescent stain for intracellular lipid droplets. JCell Biol 1985, 100:965-973.
14. Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008, 17:1411-1417.
15. Ma Z., Haddadi A., Molavi O., Lavasanifar A., Lai R., Samuel J. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. JBiomed Mater Res A 2008, 86:300-310.
16. MacLachlan J., Wotherspoon A.T., Ansell R.O., Brooks C.J. Cholesterol oxidase: sources, physical properties and analytical applications. JSteroid Biochem Mol Biol 2000, 72:169-195.
17. Lehnus G., Smith L. Automated procedure for kinetic measurement of total triglycerides (as glycerol) in serum with the Gilford System 3500. Clin Chem 1978, 24:27-31.
18. Duncombe W.G. The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 1964, 9:122-125.
19. Costello J., Scott J.M., Bourke E. Enzymic method for determining the specific activity of glucose. Anal Biochem 1972, 46:654-659.
20. Morgan C., Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes 1973, 31:187.
21. Schefe J.H., Lehmann K.E., Buschmann I.R., Unger T., Funke-Kaiser H. Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. JMol Med (Berlin, Germany) 2006, 84:901-910.
22. Boisvert W.A., Rose D.M., Johnson K.A., Fuentes M.E., Lira S.A., Curtiss L.K., et al. Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 2006, 168:1385-1395.
23. Chen H., Lin A.S., Li Y., Reiter C.E., Ver M.R., Quon M.J. Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion. JBiol Chem 2008, 283:29228-29238.
24. Chung Y.W., Kim H.K., Kim I.Y., Yim M.B., Chock P.B. Dual function of protein kinase C (PKC) in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced manganese superoxide dismutase (MnSOD) expression: activation of CREB and FOXO3a by PKC-alpha phosphorylation and by PKC-mediated inactivation of Akt, respectively. JBiol Chem 2011, 286:29681-29690.
25. Min K.J., Um H.J., Cho K.H., Kwon T.K. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. Food Chem Toxicol Int J Publish Brit Indust Biol Res Assoc 2013, 58C:77-85.
26. de Ruyter J.C., Olthof M.R., Seidell J.C., Katan M.B. Atrial of sugar-free or sugar-sweetened beverages and body weight in children. NEngl J Med 2012, 367:1397-1406.
27. Asai A., Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. JNutr 2001, 131:2932-2935.
28. Weisberg S.P., Leibel R., Tortoriello D.V. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008, 149:3549-3558.
29. Dam H., Glavind J. Factors influencing capillary permeability in the vitamin e deficient chick. Science 1942, 96:235-236.
30. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55:2180-2191.
31. Shao W., Yu Z., Chiang Y., Yang Y., Cha iT., Holtz w, et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating Lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One 2012, 7(1).
32. Prakash U.N., Srinivasan K. Fat digestion and absorption in spice-pretreated rats. JSci Food Agric 2012, 92:503-510.
33. Srinivasan K., Sambaiah K., Chandrasekhara N. Spices as beneficial hypolipidemic food adjuncts: a review. Food Rev Int 2004, 20:187-220.
34. Dou X., Fan C., Wo L., Yan J., Qian Y., Wo X. Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Planta Medica 2008, 74:1374-1379.
35. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., et al. Mechanism of free fatty acid-induced insulin resistance in humans. JClin Invest 1996, 97:2859-2865.
36. Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians 1999, 111:241-248.
37. Soler-Argilaga C., Infante R., Renaud G., Polonovski J. Factors influencing free fatty acid uptake by the isolated perfused rat liver. Biochimie 1974, 56:757-761.
38. Jang E.M., Choi M.S., Jung U.J., Kim M.J., Kim H.J., Jeon S.M., et al. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism 2008, 57:1576-1583.
39. Dali-Youcef N., Mecili M., Ricci R., Andres E. Metabolic inflammation: connecting obesity and insulin resistance. Ann Med 2013, 45:242-253.
40. Morino K., Petersen K.F., Shulman G.I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006, 55(Suppl.2):S9-S15.
41. Samuel V.T., Liu Z.X., Qu X., Elder B.D., Bilz S., Befroy D., et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. JBiol Chem 2004, 279:32345-32353.
42. Zingg J.M., Hasan S.T., Meydani M. Molecular mechanisms of hypolipidemic effects of curcumin. Biofactors 2013, 39:101-121.
43. Rao D.S., Sekhara N.C., Satyanarayana M.N., Srinivasan M. Effect of curcumin on serum and liver cholesterol levels in the rat. JNutr 1970, 100:1307-1315.
44. Kim M., Kim Y. Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet. Nutr Res Pract 2010, 4:191-195.
45. Manjunatha H., Srinivasan K. Hypolipidemic and antioxidant effects of dietary curcumin and capsaicin in induced hypercholesterolemic rats. Lipids 2007, 42:1133-1142.
46. Bechmann L.P., Hannivoort R.A., Gerken G., Hotamisligil G.S., Trauner M., Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. JHepatol 2012, 56:952-964.
47. Shapiro H., Bruck R. Therapeutic potential of curcumin in non-alcoholic steatohepatitis. Nutr Res Rev 2005, 18:212-221.
48. Zhao J.F., Ching L.C., Huang Y.C., Chen C.Y., Chiang A.N., Kou Y.R., et al. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Mol Nutr Food Res 2012, 56:691-701.
49. Diepvens K., Westerterp K.R., Westerterp-Plantenga M.S. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol 2007, 292:R77-R85.
50. Baum L., Cheung S.K., Mok V.C., Lam L.C., Leung V.P., Hui E., et al. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol Res 2007, 56:509-514.
51. Alwi I., Santoso T., Suyono S., Sutrisna B., Suyatna F.D., Kresno S.B., et al. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Medica Indones 2008, 40:201-210.
52. Boord J.B., Fazio S., Linton M.F. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 2002, 13:141-147.
53. Tuncman G., Erbay E., Hom X., De Vivo I., Campos H., Rimm E.B., et al. Agenetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci U S A 2006, 103:6970-6975.
54. Ordovas J.M. Identification of a functional polymorphism at the adipose fatty acid binding protein gene (FABP4) and demonstration of its association with cardiovascular disease: a path to follow. Nutr Rev 2007, 65:130-134.
55. Peschel D., Koerting R., Nass N. Curcumin induces changes in expression of genes involved in cholesterol homeostasis. JNutr Biochem 2007, 18:113-119.
56. Na L.X., Zhang Y.L., Li Y., Liu L.Y., Li R., Kong T., et al. Curcumin improves insulin resistance in skeletal muscle of rats. Nutr, Metab, Cardiovasc Dis NMCD 2011, 21:526-533.
57. Zingg J.M., Hasan S.T., Cowan D., Ricciarelli R., Azzi A., Meydani M. Regulatory effects of curcumin on lipid accumulation in monocytes/macrophages. JCell Biochem. 2012, 113:833-840.
58. Mimche P.N., Thompson E., Taramelli D., Vivas L. Curcumin enhances non-opsonic phagocytosis of Plasmodium falciparum through up-regulation of CD36 surface expression on monocytes/macrophages. JAntimicrob Chemother 2012, 67:1895-1904.
59. Sharma R.A., Gescher A.J., Steward W.P. Curcumin: the story so far. Eur J Cancer 2005, 41:1955-1968.
60. Kim K.-H., Lee E.N., Park J.K., Lee J.-R., Kim J.-H., Choi H.-J., et al. Curcumin attenuates TNF-alpha-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells. Phytother Res PTR 2012, 26:1037-1047.
61. Jukema J.W., Cannon C.P., de Craen A.J., Westendorp R.G., Trompet S. The controversies of statin therapy: weighing the evidence. JAm Coll Cardiol 2012, 60:875-881.
62. Rossato M., Curtale G., Tamassia N., Castellucci M., Mori L., Gasperini S., et al. IL-10-induced microRNA-187 negatively regulates TNF-alpha, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc Natl Acad Sci U S A 2012, 109:E3101-E3110.
63. Bayet-Robert M., Morvan D. Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel. PLoS One 2013, 8:e57971.